Form 483

Nexgen Pharma Inc Form 483, 2017-10-20

FDA issued a Form 483 to Nexgen Pharma Inc on 2017-10-20 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Nexgen Pharma Inc · Irvine, United States · Issued October 20, 2017

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 4 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 Oct 2017
21 CFR 211.130(e)

Packaging line inspection documentation

Cited by Bryan A Galvez, Truong X Nguyen, Christopher D Washington, Vioela J Caze

20 Oct 2017
21 CFR 211.142

Written warehousing procedures established/followed

Cited by Bryan A Galvez, Truong X Nguyen, Christopher D Washington, Vioela J Caze

20 Oct 2017
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Bryan A Galvez, Truong X Nguyen, Christopher D Washington, Vioela J Caze

20 Oct 2017
21 CFR 211.192

No written record of investigation

Cited by Bryan A Galvez, Truong X Nguyen, Christopher D Washington, Vioela J Caze

20 Oct 2017
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Bryan A Galvez, Truong X Nguyen, Christopher D Washington, Vioela J Caze

Inspected site

NPNexgen Pharma IncIrvine, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.130(e)Cited across public-safe Form 483 observations1x
21 CFR 211.142Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere